Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_assertion type Assertion NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_head.
- NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_assertion description "[The proportion of individuals with innate slow mEPHX activity (homozygotes) was significantly higher in both the COPD group and the emphysema group than in the control group (COPD 13 [19%] vs control 13 [6%]; emphysema 21 [22%] vs 13 [6%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_provenance.
- NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_assertion evidence source_evidence_literature NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_provenance.
- NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_assertion SIO_000772 10193341 NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_provenance.
- NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_assertion wasDerivedFrom befree-20140225 NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_provenance.
- NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_assertion wasGeneratedBy ECO_0000203 NP418007.RAZ6_n1AeMIUlzciBTB61WQ-NOuR2nKMjgRF0eZsvVt-Q130_provenance.